From todays Fairfax Media, Merchant Funds are still seemingly investors in MMJ:
"Chapman (Andrew) says his fund was one of the first backers of the industry, investing in Phytotech, the first to list on the ASX.
While Phytotech had a volatile start to life, jumping in value more than fourfold to 92¢ in its first two days trading and plunging back to 28¢ when its founder Smith quit following the social media scandal, it was now trading at 62¢"
The article is titled "How high is too high for Australia's cannabis stocks". Due to copyright restrictions, I will not copy and paste the whole article. There is some interesting information regarding market potential which seemingly concurs with what I've relayed prior with HL Pharma and the Gelpell.
MMJ Price at posting:
59.0¢ Sentiment: Buy Disclosure: Held
